ahlam1399
05-29-2015, 11:38 AM
BRIEF-AstraZeneca to collaborate with Lilly on solid tumours clinical trial
* Astrazeneca and lilly to collaborate on immu**-oncology combination clinical trial in solid tumourshttp://i2.wp.com/reuters.us.feedsportal.com/c/35217/f/654213/s/46bed3e2/sc/14/mf.gif?resize=1%2C1
http://da.feedsportal.com/r/228767811938/u/49/f/654213/c/35217/s/46bed3e2/sc/14/rc/1/rc.img (http://da.feedsportal.com/r/228767811938/u/49/f/654213/c/35217/s/46bed3e2/sc/14/rc/1/rc.htm)
http://da.feedsportal.com/r/228767811938/u/49/f/654213/c/35217/s/46bed3e2/sc/14/rc/2/rc.img (http://da.feedsportal.com/r/228767811938/u/49/f/654213/c/35217/s/46bed3e2/sc/14/rc/2/rc.htm)
http://da.feedsportal.com/r/228767811938/u/49/f/654213/c/35217/s/46bed3e2/sc/14/rc/3/rc.img (http://da.feedsportal.com/r/228767811938/u/49/f/654213/c/35217/s/46bed3e2/sc/14/rc/3/rc.htm)
http://da.feedsportal.com/r/228767811938/u/49/f/654213/c/35217/s/46bed3e2/sc/14/a2.img (http://da.feedsportal.com/r/228767811938/u/49/f/654213/c/35217/s/46bed3e2/sc/14/a2.htm)
http://adchoice.feedsportal.com/r/228767811938/u/49/f/654213/c/35217/s/46bed3e2/sc/14/ach.img (http://adchoice.feedsportal.com/r/228767811938/u/49/f/654213/c/35217/s/46bed3e2/sc/14/ach.htm)http://pi.feedsportal.com/r/228767811938/u/49/f/654213/c/35217/s/46bed3e2/sc/14/a2t.imghttp://pi2.feedsportal.com/r/228767811938/u/49/f/654213/c/35217/s/46bed3e2/sc/14/a2t2.imghttp://feeds.feedburner.com/~ff/reuters/companyNews?d=yIl2AUoC8zA (http://feeds.reuters.com/~ff/reuters/companyNews?a=1CtXfcl_H_c:pSRmtgCVaWw:yIl2AUoC8zA) http://feeds.feedburner.com/~ff/reuters/companyNews?i=1CtXfcl_H_c:pSRmtgCVaWw:V_sGLiPBpWU (http://feeds.reuters.com/~ff/reuters/companyNews?a=1CtXfcl_H_c:pSRmtgCVaWw:V_sGLiPBpWU) http://feeds.feedburner.com/~ff/reuters/companyNews?i=1CtXfcl_H_c:pSRmtgCVaWw:F7zBnMyn0Lo (http://feeds.reuters.com/~ff/reuters/companyNews?a=1CtXfcl_H_c:pSRmtgCVaWw:F7zBnMyn0Lo)
http://feeds.feedburner.com/~r/reuters/companyNews/~4/1CtXfcl_H_c
* Astrazeneca and lilly to collaborate on immu**-oncology combination clinical trial in solid tumourshttp://i2.wp.com/reuters.us.feedsportal.com/c/35217/f/654213/s/46bed3e2/sc/14/mf.gif?resize=1%2C1
http://da.feedsportal.com/r/228767811938/u/49/f/654213/c/35217/s/46bed3e2/sc/14/rc/1/rc.img (http://da.feedsportal.com/r/228767811938/u/49/f/654213/c/35217/s/46bed3e2/sc/14/rc/1/rc.htm)
http://da.feedsportal.com/r/228767811938/u/49/f/654213/c/35217/s/46bed3e2/sc/14/rc/2/rc.img (http://da.feedsportal.com/r/228767811938/u/49/f/654213/c/35217/s/46bed3e2/sc/14/rc/2/rc.htm)
http://da.feedsportal.com/r/228767811938/u/49/f/654213/c/35217/s/46bed3e2/sc/14/rc/3/rc.img (http://da.feedsportal.com/r/228767811938/u/49/f/654213/c/35217/s/46bed3e2/sc/14/rc/3/rc.htm)
http://da.feedsportal.com/r/228767811938/u/49/f/654213/c/35217/s/46bed3e2/sc/14/a2.img (http://da.feedsportal.com/r/228767811938/u/49/f/654213/c/35217/s/46bed3e2/sc/14/a2.htm)
http://adchoice.feedsportal.com/r/228767811938/u/49/f/654213/c/35217/s/46bed3e2/sc/14/ach.img (http://adchoice.feedsportal.com/r/228767811938/u/49/f/654213/c/35217/s/46bed3e2/sc/14/ach.htm)http://pi.feedsportal.com/r/228767811938/u/49/f/654213/c/35217/s/46bed3e2/sc/14/a2t.imghttp://pi2.feedsportal.com/r/228767811938/u/49/f/654213/c/35217/s/46bed3e2/sc/14/a2t2.imghttp://feeds.feedburner.com/~ff/reuters/companyNews?d=yIl2AUoC8zA (http://feeds.reuters.com/~ff/reuters/companyNews?a=1CtXfcl_H_c:pSRmtgCVaWw:yIl2AUoC8zA) http://feeds.feedburner.com/~ff/reuters/companyNews?i=1CtXfcl_H_c:pSRmtgCVaWw:V_sGLiPBpWU (http://feeds.reuters.com/~ff/reuters/companyNews?a=1CtXfcl_H_c:pSRmtgCVaWw:V_sGLiPBpWU) http://feeds.feedburner.com/~ff/reuters/companyNews?i=1CtXfcl_H_c:pSRmtgCVaWw:F7zBnMyn0Lo (http://feeds.reuters.com/~ff/reuters/companyNews?a=1CtXfcl_H_c:pSRmtgCVaWw:F7zBnMyn0Lo)
http://feeds.feedburner.com/~r/reuters/companyNews/~4/1CtXfcl_H_c